Gilead Fights For Hepa C Drug Patents: Activists Concerned About Drug Accessibility Gilead is facing opposition in five countries for its patent applications for Sovaldi, a hepatitis C drug. Activists launched the patent oppositions to ensure access to treatment for the disease. by Dianne Depra